Methods and compositions for reduction of immunogenicity

• 收藏
• 分享

专利权人:

Celgene Corporation

发明人:

Johnson, Jeffrey C.,Dearth, Lawrence,Hadjivassiliou, Haralambos,Sun, Jeonghoon,Hariharan, Kandasamy

申请号：

AU2018244276

公开号：

AU2018244276A1

申请日:

2018.03.26

申请国别(地区):

AU

年份:

2019

代理人:

摘要：

Provided herein are methods and uses involving the combination of an anti-CD20 antibody, e.g., rituximab with a protein therapeutic, for example, an antibody (e.g., an antibody that specifically binds to human CD47).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/